findmyKOL
Clinical trialNCT00024362UnknownPhase 2Interventional

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

SponsorTheradexPancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • George L. Miller, MD

    Oklahoma Oncology, Incorporated at LaFortune Cancer Center

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Oncology Associates

    Tucson, Arizona, United States

  • Alta Bates Comprehensive Cancer Center

    Berkeley, California, United States

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University

    Chicago, Illinois, United States

  • Albert B. Chandler Medical Center, University of Kentucky

    Lexington, Kentucky, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Oklahoma Oncology Inc.

    Tulsa, Oklahoma, United States

  • Boston Baskin Cancer Group, University Tennessee Oncology/hematology Group

    Memphis, Tennessee, United States

  • Cancer Center at the University of Virginia

    Charlottesville, Virginia, United States

  • Massey Cancer Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2001
Primary completion
Completion
Last update posted
24 Jul 2008
Registered enrollment
Registry id
NCT00024362

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.